Membrane transporters as mediators of synaptic dopamine dynamics: implications for disease
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Dopamine was first identified as a neurotransmitter localized to the midbrain over 50 years ago. The dopamine transporter (DAT;SLC 6A3) and the vesicular monoamine transporter 2 (VMAT 2;SLC 18A2) are regulators of dopamine homeostasis in the presynaptic neuron.DAT transports dopamine from the extracellular space into the cytosol of the presynaptic terminal.VMAT 2 then packages this cytosolic dopamine into vesicular compartments for subsequent release upon neurotransmission. Thus,DAT and VMAT 2 act in concert to move the transmitter efficiently throughout the neuron. Accumulation of dopamine in the neuronal cytosol can trigger oxidative stress and neurotoxicity, suggesting that the proper compartmentalization of dopamine is critical for neuron function and risk of disease. For decades, studies have examined the effects of reduced transporter function in mice (e.g.DAT‐KO,VMAT 2‐KO,VMAT 2‐deficient). However, we have only recently been able to assess the effects of elevated transporter expression using BAC transgenic methods (DAT‐tg,VMAT 2‐HI mice). Complemented with in vitro work and neurochemical techniques to assess dopamine compartmentalization, a new focus on the importance of transporter proteins as both models of human disease and potential drug targets has emerged. Here, we review the importance of DAT and VMAT 2 function in the delicate balance of neuronal dopamine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Parkinson's disease: clinical features and diagnosis
Jankovic, J. (2008) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.131045 · Cited by 5,720
The molecular neurobiology of depression
Krishnan, V., & Nestler, E. J. (2008) · Nature · doi:10.1038/nature07455 · Cited by 2,889 · cited 1×
“Exemplified by the dramatic mood changes observed in patients taking the VMAT2 inhibitor, reserpine (Krishnan and Nestler, 2008).”
Südhof, T. C. (2004) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.26.041002.131412 · Cited by 2,547 · cited 2×
“Synaptic vesicles are small spherical lipid bilayers formed in the Golgi apparatus and transported to the synaptic terminal (Zimmermann et al., 1993; S€udhof, 2004).”
Kinetic Stabilization of the α-Synuclein Protofibril by a Dopamine-α-Synuclein Adduct
Conway, K. A., Rochet, J.-C., Bieganski, R. M., & Lansbury, P. T. (2001) · Science · doi:10.1126/science.1063522 · Cited by 1,127
Oxidative Pathways for Catecholamines in the Genesis of Neuromelanin and Cytotoxic Quinones
GRAHAM, D. G. (1978) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13535-9 · Cited by 1,126 · cited 1×
“Cytosolic dopamine can also be autooxidized to form reactive oxygen species, including hydroxyl radicals, superoxide and hydrogen peroxide (Graham, 1978; Jenner, 2003).”
Catecholamine Metabolism: A Contemporary View with Implications for Physiology and Medicine
Eisenhofer, G., Kopin, I. J., & Goldstein, D. S. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.3.1 · Cited by 1,072 · cited 2×
“Dopamine can be deaminated by mitochondrial monoamine oxidase (MAO), which converts cytosolic dopamine to DOPAL, a reactive aldehyde intermediate, and hydrogen peroxide (Eisenhofer et al., 2004; Rees et al., 2009; Goldstein et al., 2013).”
sagvolden, T., johansen, E. B., aase, H., & russell, V. A. (2005) · Behavioral and Brain Sciences · doi:10.1017/s0140525x05000075 · Cited by 1,035
Role of Serotonin in the Paradoxical Calming Effect of Psychostimulants on Hyperactivity
Gainetdinov, R. R., Wetsel, W. C., Jones, S. R., Levin, E. D., Jaber, M., & Caron, M. G. (1999) · Science · doi:10.1126/science.283.5400.397 · Cited by 885 · cited 2×
“Pharmacologically, DAT-KO mice are insensitive to the classical stimulant actions of cocaine and amphetamine but show paradoxical calming effects instead (Gainetdinov et al., 1999; Giros et al., 1996).”
Classic toxin-induced animal models of Parkinson?s disease: 6-OHDA and MPTP
Schober, A. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0938-y · Cited by 803
Sulzer, D., Chen, T., Lau, Y., Kristensen, H., Rayport, S., & Ewing, A. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-05-04102.1995 · Cited by 688
Cited by
Parkinson’s Disease: From Pathogenesis to Pharmacogenomics
Cacabelos, R. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030551 · Cited by 555
Oxidative Stress: Signaling Pathways, Biological Functions, and Disease
Liu, S., Liu, J., Wang, Y., Deng, F., & Deng, Z. (2025) · MedComm · doi:10.1002/mco2.70268 · Cited by 359
Employing Conductive Metal–Organic Frameworks for Voltammetric Detection of Neurochemicals
Ko, M., Mendecki, L., Eagleton, A. M., Durbin, C. G., Stolz, R. M., Meng, Z., & Mirica, K. A. (2020) · Journal of the American Chemical Society · doi:10.1021/jacs.9b13402 · Cited by 298
Monzani, E., Nicolis, S., Dell'Acqua, S., Capucciati, A., Bacchella, C., Zucca, F. A., Mosharov, E. V., Sulzer, D., Zecca, L., & Casella, L. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201811122 · Cited by 271
Impaired dopamine release in Parkinson’s disease
Cramb, K. M. L., Beccano-Kelly, D., Cragg, S. J., & Wade-Martins, R. (2023) · Brain · doi:10.1093/brain/awad064 · Cited by 207
“overexpression of DAT decreases DA release through different mechanisms.(113) Models of Parkinson’s disease with mutations in SNCA, Vps35, DJ-1, parkin and LRRK2 have reported alterations in DAT levels or function.”
BackgroundDopamine gene methylation patterns are associated with obesity markers and carbohydrate intake
Ramos‐Lopez, O., Riezu‐Boj, J. I., Milagro, F. I., Martinez, J. A., & MENA Project (2018) · Brain and Behavior · doi:10.1002/brb3.1017 · Cited by 33
Lim, H.-S., Moon, B. C., Lee, J., Choi, G., & Park, G. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.07.010 · Cited by 30
Supplementation with l-arginine and nitrates vs age and individual physiological reactivity
Kurhaluk, N. (2024) · Nutrition Reviews · doi:10.1093/nutrit/nuad131 · Cited by 12
Metadata
- Authors
- Lohr, K. M., Masoud, S. T., Salahpour, A., & Miller, G. W.
- Venue
- European Journal of Neuroscience
- Publisher
- Wiley
- Published
- 2016-09-02
- Volume
- 45
- Issue
- 1
- Pages
- 20-33
- ISSN
- 0953-816X (ISSN-L)
- 1460-9568
- OpenAlex
- W2517975703
- Cited by
- 124
- References
- 22
- FWCI
- 6.35
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.